Albert Cha is Director of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of KALV, which is worth approximately $0. The most recent transaction as insider was on Sep 11, 2023, when has been sold 18,000 shares (Common Stock) at a price of $10.5 per share, resulting in proceeds of $189,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Albert Cha Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2023
SELL
Open market or private sale
$189,000 $10.5 p/Share
18,000 Reduced 100.0%
0 Common Stock
Sep 11 2023
BUY
Exercise of conversion of derivative security
$131,400 $7.3 p/Share
18,000 Added 50.0%
18,000 Common Stock
AC

Albert Cha

Director
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV